Skip to content

Clinical trials

Phase 1/2 Triple Negative Breast Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20182
20191
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Completed2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
BioAtla, Inc.1
Bristol-Myers Squibb1
Kymab Limited1
Novartis Pharmaceuticals1
Numab Therapeutics AG1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Melanoma4
Squamous Cell Carcinoma of Head and Neck3
Breast Neoplasms2
Stomach Neoplasms2
Carcinoma1
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Carcinoma, Squamous Cell1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.